Trial site
University of New Mexico Health Sciences Center
- 13running trials
- 10closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- High blood pressure4 trials
- Pulmonary arterial hypertension4 trials
- Stroke4 trials
- Obesity3 trials
- Vitiligo3 trials
- Alopecia areata2 trials
- Idiopathic pulmonary fibrosis2 trials
- Long COVID and ME/CFS2 trials
- Atrial fibrillation1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Irritable bowel syndrome1 trial
- Phase
- Phase 313 trials
- Early phase 11 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Completed10 trials
- Recruiting7 trials
- Active, not recruiting5 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Lead sponsor
- Pfizer5 trials
- University of New Mexico4 trials
- United Therapeutics3 trials
- GB002, Inc.2 trials
- NYU Langone Health2 trials
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Stroke2 recruiting
- Alopecia areata1 recruiting
- Atrial fibrillation1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- High blood pressure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Completed
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
Completed
Completed
Completed
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
Completed
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Completed
Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care
Completed
Modifiers of Disease Severity in Cerebral Cavernous Malformations
Site data: ClinicalTrials.govUpdated 19 Nov 2026